Dedicated to Clinical-Grade Peptide Synthesis

 

At Synedica Labs, we are committed to bridging the gap between cutting-edge molecular research and uncompromising quality. Based in the UK, we specialise in the synthesis, purification, and distribution of high-calibre metabolic research peptides.

Our focus is clear: delivering highly stable, laboratory-grade compounds that researchers can rely on for consistent, reproducible data.

 

Our Scientific Standard

 

We believe that breakthrough research is only as good as the purity of its ingredients. Every batch of peptides we produce undergoes strict analytical verification—including High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS)—to guarantee a minimum purity level of 99%.

Whether your team is studying dual-agonist pathways with synedica tirzepatide or exploring the limits of triple-agonist kinetics with synedica retatrutide, our formulations are synthesised to meet the most exacting global standards.

While some of our clinical partners occasionally locate us using the spelling variation syndica, our official, quality-assured brand is Synedica Labs. We operate with absolute transparency, providing open-access batch analysis to verify our structural claims.

Scientific precision does not stop at synthesis. Overcoming the challenges of peptide degradation during shipping and handling is central to our mission.

• State-of-the-Art Solutions:, We have pioneered highly stable liquid and lyophilised options, including our widely used synedica tirzepatide 40mg vials and ready-to-analyse synedica retatrutide 40mg kits.

• Precision Research Tools: To support advanced dosing protocols, we developed the synedica retatrutide 40mg pen, designed specifically to reduce reconstitution errors and preserve chemical integrity.

• All-in-One Kits: For laboratories requiring a complete setup, we provide the fully integrated retatrutide 40mg injection pen kit, complete with sterile accessories and storage guidance.